Clinical Trial Update: A Study to Assess the Safety and Pharmacokinetics of GDC-8264 in Combination With Standard of Care in Participants With Acute Graft-Versus-Host Disease (aGVHD) [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates the safety and pharmacokinetics of GDC-8264 in combination with standard of care in participants with acute graft-versus-host disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• GDC-8264

Snippet

Sponsor: Genentech, Inc. | Conditions: Acute Graft-versus-host Disease | Phase 1 | Status: COMPLETED | Results posted: 2025-04-24